Home » Topics » BioWorld Science

BioWorld Science
RSS

Circulating galectin-1 as a predictive biomarker of CAD and MACE in patients with stable angina

Sep. 6, 2019

CAD-1883 demonstrates promising safety in phase I study

Sep. 6, 2019

Potent AXL kinase inhibitor with promising in vitro and in vivo biological activity

Sep. 6, 2019

An organoid model for prenatal brain development

Sep. 6, 2019

Dystrophy mutation protects cells from HIV infection

Sep. 6, 2019

ADC traffic rules revealed

Sep. 6, 2019

New trials evaluate IPI-549 in combination therapies for solid tumors

Sep. 5, 2019

Gilead Sciences initiates phase Ib/II study of GS-4224 in advanced solid tumors

Sep. 5, 2019

CellCentric initiates phase I/IIa study of CCS-1477 in hematological malignancies

Sep. 5, 2019

Applied Therapeutics begins phase III study of AT-1001 for diabetic cardiomyopathy

Sep. 5, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...